Nationwide cohort study suggests that nucleos(t)ide analogue therapy decreases dialysis risk in Taiwanese chronic kidney disease patients acquiring hepatitis B virus infection

AIM: To investigate the risk of end-stage renal disease (ESRD) in hepatitis B virus (HBV)-infected patients with chronic kidney disease (CKD) with and without nucleos(t)ide analogue (NA) therapy. METHODS: This nationwide cohort study included 103444 Taiwanese CKD adults without hepatitis C virus inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yi-Chun, Li, Chung-Yi, Tsai, Shiang-Jiun, Chen, Yen-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Retrospective Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829155/
https://www.ncbi.nlm.nih.gov/pubmed/29491685
http://dx.doi.org/10.3748/wjg.v24.i8.917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829155/
https://www.ncbi.nlm.nih.gov/pubmed/29491685
http://dx.doi.org/10.3748/wjg.v24.i8.917

Ejemplares similares